SCHEMBL31214780

CC(C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)O

nearest known ligand 0.52

Predicted protein targets (top 16)

	gene	UniProt	supporting neighbours	confidence
▸	EPHA2	P29317	5/20	0.52

▸	CALCRL	Q16602	5/20	0.47

▸	CXCR4	P61073	1/20	0.41

▸	KDM1A	O60341	1/20	0.40

▸	MAOB	P27338	1/20	0.40

▸	KDM5A	P29375	1/20	0.40

▸	KDM1B	Q8NB78	1/20	0.40

▸	KEAP1	Q14145	1/20	0.40

▸	NRP1	O14786	1/20	0.40

▸	OPRM1	P35372	2/20	0.40

▸	OPRK1	P41145	2/20	0.40

▸	PRMT5	O14744	1/20	0.39

▸	WDR77	Q9BQA1	1/20	0.39

▸	REN	P00797	1/20	0.39

▸	ACE	P12821	1/20	0.39

▸	PLK1	P53350	1/20	0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL29743137	0.95	EPHA2 (0.50)	EPHA2CALCRLCXCR4OPRM1OPRK1
SCHEMBL9551335	0.93	EPHA2 (0.46)	EPHA2CALCRLCXCR4KDM1AMAOB
SCHEMBL30443975	0.92	ACE (0.45)	EPHA2CALCRLKDM1AMAOBKDM5A
SCHEMBL31039948	0.90	CXCR4 (0.47)	EPHA2CXCR4KDM1AMAOBKDM5A
SCHEMBL29659402	0.90	EPHA2 (0.48)	EPHA2CALCRL
SCHEMBL29743133	0.90	EPHA2 (0.48)	EPHA2CALCRL
SCHEMBL30173901	0.89	ACE (0.44)	EPHA2KDM1AMAOBKDM5AKDM1B
SCHEMBL29577010	0.88	CALCRL (0.47)	EPHA2CALCRLKEAP1RENACE
SCHEMBL30957282	0.86	EPHA2 (0.49)	EPHA2CALCRLCXCR4OPRM1OPRK1
SCHEMBL29802045	0.84	OPRK1 (0.49)	CXCR4NRP1OPRM1OPRK1ACE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
CN-118615422-A	Application of polypeptide P2 in preparation of medicines for treating pulmonary fibrosis diseases	中国药科大学	2024-09-10	—	—	CN	disclosed